HU9203921D0 - Method for producing pharamceutical preparatives of modaphinyl content - Google Patents

Method for producing pharamceutical preparatives of modaphinyl content

Info

Publication number
HU9203921D0
HU9203921D0 HU9203921A HU392192A HU9203921D0 HU 9203921 D0 HU9203921 D0 HU 9203921D0 HU 9203921 A HU9203921 A HU 9203921A HU 392192 A HU392192 A HU 392192A HU 9203921 D0 HU9203921 D0 HU 9203921D0
Authority
HU
Hungary
Prior art keywords
modaphinyl
pharamceutical
preparatives
producing
content
Prior art date
Application number
HU9203921A
Other languages
English (en)
Hungarian (hu)
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of HU9203921D0 publication Critical patent/HU9203921D0/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9203921A 1991-12-13 1992-12-11 Method for producing pharamceutical preparatives of modaphinyl content HU9203921D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115534A FR2684875B1 (fr) 1991-12-13 1991-12-13 Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.

Publications (1)

Publication Number Publication Date
HU9203921D0 true HU9203921D0 (en) 1993-03-29

Family

ID=9420051

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203921A HU9203921D0 (en) 1991-12-13 1992-12-11 Method for producing pharamceutical preparatives of modaphinyl content
HU9203921A HU216193B (hu) 1991-12-13 1992-12-11 Eljárás isémia következményei ellen protektív hatású modafiniltartalmú gyógyászati készítmények előállítására

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9203921A HU216193B (hu) 1991-12-13 1992-12-11 Eljárás isémia következményei ellen protektív hatású modafiniltartalmú gyógyászati készítmények előállítására

Country Status (12)

Country Link
US (1) US5391576A (enExample)
EP (1) EP0547952B1 (enExample)
JP (1) JPH0825873B2 (enExample)
KR (1) KR100252390B1 (enExample)
AT (1) ATE127342T1 (enExample)
AU (1) AU656642B2 (enExample)
DE (1) DE69204639T2 (enExample)
DK (1) DK0547952T3 (enExample)
FR (1) FR2684875B1 (enExample)
HU (2) HU9203921D0 (enExample)
TW (1) TW244335B (enExample)
UA (1) UA27231C2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (enExample) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
DE19943983A1 (de) * 1999-09-14 2001-03-15 Joseph Clasen Verwendung von Modafinil zur Herstellung eines plastizitätsfördernden Arzneimittels
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
IL155322A0 (en) * 2000-10-11 2003-11-23 Cephalon Inc Compositions comprising modafinil compounds
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
WO2004075841A2 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20060024370A1 (en) 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
WO2013062316A2 (ko) * 2011-10-25 2013-05-02 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 또는 ＫＣａ3.1 채널 매개 질환 치료용 조성물
KR101345860B1 (ko) 2011-10-25 2013-12-30 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 치료용 조성물
KR101414831B1 (ko) * 2011-10-25 2014-07-04 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 ＫＣａ3.1 채널 매개 질환 치료용 조성물
EP3854409A1 (en) 2013-08-30 2021-07-28 Green Cross Wellbeing Corporation Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.

Also Published As

Publication number Publication date
EP0547952A1 (fr) 1993-06-23
DK0547952T3 (da) 1996-01-22
FR2684875A1 (fr) 1993-06-18
HUT67784A (en) 1995-04-28
JPH0665070A (ja) 1994-03-08
EP0547952B1 (fr) 1995-09-06
US5391576A (en) 1995-02-21
DE69204639D1 (de) 1995-10-12
ATE127342T1 (de) 1995-09-15
AU3008092A (en) 1993-06-17
FR2684875B1 (fr) 1995-05-24
TW244335B (enExample) 1995-04-01
JPH0825873B2 (ja) 1996-03-13
AU656642B2 (en) 1995-02-09
KR100252390B1 (ko) 2000-05-01
HU216193B (hu) 1999-05-28
KR930012022A (ko) 1993-07-20
DE69204639T2 (de) 1996-04-04
UA27231C2 (uk) 2000-08-15

Similar Documents

Publication Publication Date Title
HUT67784A (en) Process for producing anti-ischaemic pharamceutical preparations containing modafinil
HUT64764A (en) Carbapenem-derivatives with antibiotic effect and medical preparatives containing them and process for the production thereof
ZA92119B (en) Method and apparatus for the production of plastic lenses.
IL107248A0 (en) Apparatus for treatment of the oral cavity
IL94817A0 (en) Apparatus and method for the treatment of a tooth
SG44545A1 (en) Apparatus and method for producing patterned molding articles
HUT65318A (en) Beta-sitostanol-fatty-acid-esters lowering of cholesterol-level in serum and process for the production of these
AU2140492A (en) Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
GB2203674B (en) Process for producing co2 and/or n2
GB2274944B (en) Field effect transistor and method for producing the field effect transistor
EP0506560A3 (en) Window with integrated hologram and process for making the hologram
GR3022446T3 (en) Apparatus for the continuous treatment of a linear manufacture
EP0674707A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA.
EP0638357A3 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung.
GB9116521D0 (en) Crosslinkable acrylic rubber and method for producing the same
CS293191A3 (en) Process for producing column-like body and apparatus for making the same
ZA922111B (en) Process and apparatus for the production of argon
EP0306841A3 (en) Mold surface treatment process and mold
EP0507417A3 (en) Process for the selective reduction of the 4-halogen in 2,4-dihaloanilines
EP0665099A3 (de) Verfahren und Vorrichtung zur Herstellung von Laminatplatten und danach sowie damit hergestelltes Laminatplatten-Formteil.
GB9425072D0 (en) Apparatus for treating patients with hyperbaric oxygen
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
HU911860D0 (en) Process for separing and purifying 1-methyl-2-pyrrholidinyl-ethanol enantiomers
HU9303471D0 (en) Process and device for producing leaven
GB9110999D0 (en) Method and apparatus for producing ozone